Literature DB >> 8795591

Influence of smoking in the glutathione-S-transferase M1 deficiency--associated risk for squamous cell carcinoma of the bladder in schistosomiasis patients in Egypt.

A Lafuente1, M M Zakahary, M A el-Aziz, C Ascaso, M J Lafuente, M Trias, P Carretero.   

Abstract

In this study we show an effect of the glutathione-S-transferase M1 (GSTM1) null phenotype on the risk for squamous cell carcinoma (SCC) of the bladder among male smokers in Egypt, with an adjusted odds ratio of 4.8 (95% confidence interval: 1.06-21.77). However, no overall effect of the GSTM1 null phenotype on the risk for bladder SCC was observed.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8795591      PMCID： PMC2074697          DOI： 10.1038/bjc.1996.445

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  21 in total

Review 1.  Involvement of alkylating agents in schistosome-associated bladder cancer: the possible basic mechanisms of induction.

Authors:  A F Badawi; M H Mostafa; P J O'Connor
Journal:  Cancer Lett       Date:  1992-04-30       Impact factor: 8.679

Review 2.  The epidemiology of bladder cancer: a second look.

Authors:  E L Wynder; R Goldsmith
Journal:  Cancer       Date:  1977-09       Impact factor: 6.860

3.  Smoking and cancer of the lower urinary tract.

Authors:  P Cole; R R Monson; H Haning; G H Friedell
Journal:  N Engl J Med       Date:  1971-01-21       Impact factor: 91.245

4.  Genotype and phenotype of glutathione S-transferase class mu isoenzymes mu and psi in lung cancer patients and controls.

Authors:  J Brockmöller; R Kerb; N Drakoulis; M Nitz; I Roots
Journal:  Cancer Res       Date:  1993-03-01       Impact factor: 12.701

5.  Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer.

Authors:  D A Bell; J A Taylor; D F Paulson; C N Robertson; J L Mohler; G W Lucier
Journal:  J Natl Cancer Inst       Date:  1993-07-21       Impact factor: 13.506

6.  Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer.

Authors:  T Habuchi; R Takahashi; H Yamada; O Ogawa; Y Kakehi; K Ogura; S Hamazaki; J Toguchida; K Ishizaki; J Fujita
Journal:  Cancer Res       Date:  1993-08-15       Impact factor: 12.701

7.  A population and familial study of the defective alicyclic hydroxylation of debrisoquine among Egyptians.

Authors:  A Mahgoub; J R Idle; R L Smith
Journal:  Xenobiotica       Date:  1979-01       Impact factor: 1.908

Review 8.  Mechanisms of chemoprotection by oltipraz.

Authors:  T Kensler; P Styczynski; J Groopman; K Helzlsouer; T Curphey; Y Maxuitenko; B D Roebuck
Journal:  J Cell Biochem Suppl       Date:  1992

9.  Human glutathione S-transferase mu (GST mu) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers.

Authors:  A Lafuente; F Pujol; P Carretero; J P Villa; A Cuchi
Journal:  Cancer Lett       Date:  1993-01-15       Impact factor: 8.679

10.  Phenotype of glutathione S-transferase Mu (GSTM1) and susceptibility to malignant melanoma. MMM group. Multidisciplinary Malignant Melanoma Group.

Authors:  A Lafuente; R Molina; J Palou; T Castel; A Moral; M Trias
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640
View more
  2 in total

1.  GSTM1, GSTT1 null variants, and GPX1 single nucleotide polymorphism are not associated with bladder cancer risk in Egypt.

Authors:  David Goerlitz; Mai El Daly; Mohamed Abdel-Hamid; Doa'a A Saleh; Lenka Goldman; Sherif El Kafrawy; Tamer Hifnawy; Sameera Ezzat; Mohamed A Abdel-Aziz; Mohamed Saad Zaghloul; Saber Rafat Ali; Hussein Khaled; Sania Amr; Yun-Ling Zheng; Nabiel Mikhail; Christopher Loffredo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-05-17       Impact factor: 4.254

2.  Association of Glutathione S-transferase gene polymorphism with bladder Cancer susceptibility.

Authors:  Tianbiao Zhou; Hong-Yan Li; Wei-Ji Xie; Zhiqing Zhong; Hongzhen Zhong; Zhi-Jun Lin
Journal:  BMC Cancer       Date:  2018-11-12       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.